Journal
MULTIPLE SCLEROSIS AND RELATED DISORDERS
Volume 3, Issue 2, Pages 279-281Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.msard.2013.10.001
Keywords
Pseudotumoral; Multiple sclerosis; Rebound; Natalizumab; Pregnancy
Categories
Ask authors/readers for more resources
Natalizumab is a highly efficacious treatment for active relapsing-remitting multiple sclerosis, dramatically reducing both clinical and radiological signs of inflammation in most patients. The disease course after stopping treatment and especially the emergence of rebound activity are still a matter of debate. We present a case of dramatic reactivation of clinical disease activity with newly emerging pseudotumoral lesions in a patient who stopped treatment due to pregnancy. Both the clinical and radiological presentation suggest a rebound and necessitate close monitoring of patients stopping their treatment during pregnancy, even after a long period of stable disease. (C) 2013 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available